Best copper peptide eye cream: what the dermatology studies actually show

Last updated 2026-07-24

What makes a copper peptide eye cream 'best' when no product has clinical trial data?

The term 'best' on a cosmetic label means the brand's marketing team put it there. Zero eye creams containing GHK-Cu have published peer-reviewed, placebo-controlled trials specific to periorbital wrinkles or dark circles. That's not surprising: the FDA doesn't require cosmetics to prove efficacy, only that they don't cause immediate harm ^[1]. The studies researchers cite when discussing GHK-Cu and skin actually used defined peptide concentrations in lab-grade vehicles. A 2018 gene-expression analysis found GHK-Cu influenced genes related to collagen synthesis, antioxidant response, and angiogenesis ^[2]. A 2020 review noted GHK-Cu improved wound contraction, epidermal thickness, and collagen deposition in animal models at concentrations typically 0.5-2 mM (roughly 0.15-0.6 mg/mL, often formulated to deliver 2-4% active) ^[3]. Those preparations are not $45 jars with fifteen botanical extracts competing for absorption. A 2025 topical application review points out that commercial formulations rarely specify the molar ratio of copper to peptide, the pH (which governs complex stability), or whether the peptide survives the preservative system long enough to reach your skin ^[4]. The paper states, 'The cosmetic industry frequently uses GHK-Cu at unverified doses in multi-ingredient products that lack stability data.' That's the gap: research shows promise at known doses, but the products people buy don't report those doses. If you insist on over-the-counter eye cream, look for one that lists copper peptide or GHK-Cu in the top five ingredients and discloses total copper content in parts-per-million or percentage. If it doesn't, you're paying for packaging. If the brand touts 'proprietary blend,' you have no way to reproduce the result or compare it to literature. For evidence-matched concentration, talk to a provider about a compounded topical; many dermatology and regenerative-medicine clinics now dispense GHK-Cu preparations at defined strength, prepared under 21 U.S.C. 353a compounding rules ^[5].

How much GHK-Cu do dermatology studies actually use, and how does that compare to store-bought creams?

Wound-healing mouse studies that showed faster epithelialization and collagen deposition used GHK-Cu concentrations around 2 mg/mL in liposomal carriers ^[6]. Human ex-vivo skin testing for collagen IV upregulation used 10 μM GHK-Cu (about 0.003 mg/mL, a low dose by formulation standards) but combined it with hyaluronic acid and measured direct tissue response over 48 hours, not long-term wrinkle depth ^[7]. The difference matters: a brief ex-vivo assay does not predict what happens when you apply a cream nightly for three months through makeup, sunscreen, and sebum. A 2023 review on liposomal GHK-Cu formulations reports encapsulation efficiencies ranging from 50-85%, meaning only half to three-quarters of the stated peptide dose is bio-available even in well-made liposomes ^[8]. The paper also notes that unencapsulated GHK-Cu degrades rapidly in the presence of air, light, and common cosmetic preservatives like phenoxyethanol. Store that jar on a sunny bathroom counter and the active peptide is largely gone in weeks. Now look at a typical department-store eye cream ingredient list: water, glycerin, dimethicone, niacinamide, caffeine, five plant extracts, three peptides (one of which might be GHK-Cu), preservatives. If the GHK-Cu is listed eighth, it's under 1% by weight in most formulation conventions. No mass disclosed, no copper:peptide ratio, no stability test. You're trusting the brand chemist got it right and that the peptide survived the supply chain. That's fine for exploratory skincare, but don't call it evidence-based. For measurable results, people are moving to compounded topicals dispensed by medical practices. A 2025 analytical chemistry paper tested liposomal GHK-Cu formulations by capillary electrophoresis and found actual peptide content varied from 60-110% of label claim even in pharmaceutical-grade batches ^[9]. The takeaway: even honest labs have batch variation. Your $60 cream probably has less.

Can you get injectable GHK-Cu for the eye area instead of topical cream?

Yes, but it's off-label and almost entirely uncharted. Injectable peptide therapy is growing in orthopedics and sports medicine; a 2026 primer notes that GHK-Cu is sometimes used in tendon and fascia repair at 2-10 mg per injection site ^[10], and a 2026 safety review lists GHK-Cu among unapproved peptides being tried for musculoskeletal injuries, though it stresses the lack of large human trials ^[11]. None of those papers discuss periorbital injection, because the anatomy is risky: you're near the orbital septum, the infraorbital nerve, and venous plexuses that can cause hematoma or worse if you nick them. One rat ACL-reconstruction study found that GHK-Cu injected at the surgical site improved early collagen alignment and tensile strength at week four, but the effect faded by week twelve ^[12]. That's tissue repair, not cosmetic enhancement, and rodent healing timelines don't map to human eyelid skin. A 2026 review on peptides in aesthetic medicine mentions GHK-Cu for facial rejuvenation but flags the absence of dosing consensus and notes that many providers use it in combination with other peptides, making isolated attribution impossible ^[13]. If you're considering injection, you want a physician or nurse injector who has liability coverage for off-label peptide use and sources from a 503B outsourcing facility or a 503A pharmacy with a patient-specific prescription ^[5]. Injection around the eye is not DIY territory. Misjudge depth and you could end up with a nodule, asymmetry, or orbital fat prolapse that requires surgical correction. Topical application has near-zero anatomical risk; injection has real risk. Weigh that honestly. For dosing details and what concentrations appear in the literature, see our main guide. Most providers who offer injectable GHK-Cu for skin do subdermal mesotherapy at 0.5-2 mg per mL of carrier, injected in small volumes across multiple points. That's anecdotal practice, not protocol.

What other ingredients should be in a copper peptide eye cream to actually help?

If you're buying an eye cream anyway, look for ingredients with independent evidence: niacinamide at 2-5% (reduces transepidermal water loss and hyperpigmentation), caffeine at 0.5-3% (mild vasoconstrictive effect that temporarily reduces puffiness), and hyaluronic acid or sodium hyaluronate (humectant). A 2023 study found that GHK-Cu combined with hyaluronic acid increased collagen IV expression more than either compound alone in fibroblast culture ^[7], so the pairing has mechanistic logic. Avoid creams that list retinol or alpha-hydroxy acids near the top unless you're already tolerating those on your face; the periorbital area is thinner and more reactive. Copper ions themselves can be pro-oxidant in the wrong context, and combining GHK-Cu with ascorbic acid (vitamin C) can destabilize both ^[4]. If the formula includes both, they're probably in separate phases or one is in a very low concentration. Silicones like dimethicone and cyclopentasiloxane give that smooth glide and instant blurring effect but do nothing for long-term structure. They're fine as a base, but if they dominate the formula, you're mostly paying for slip. Peptides need to penetrate; a heavy occlusive layer can block that. The best formulations use a light emulsion or serum base, encapsulate the GHK-Cu in liposomes or micelles to protect it from oxidation, and keep the ingredient list under twenty items so each active is at meaningful concentration. One more thing: check the pH. GHK-Cu is most stable and retains copper-binding at pH 5-7 ^[4]. If your cream is alkaline (pH 8+), you might get peptide but not the complex. Most brands don't disclose pH, so you're flying blind.

How long does it take to see results from copper peptide eye cream?

Honestly, nobody knows for cosmetic eye creams because they haven't been tested in controlled trials with photography and validated wrinkle-depth measurement. The research that does exist used defined peptide concentrations on wounds or full-face photoaging, not crow's feet. A 2017 mouse scald-wound study using GHK-Cu liposomes showed accelerated re-epithelialization within seven days and improved collagen deposition by day fourteen ^[6]. That's wound healing, where cell turnover is rapid. Aging skin remodels slower. Collagen synthesis takes weeks to months to produce visible plumping, and you need sustained peptide delivery over that period. Anecdotally, people report seeing reduced puffiness in one to two weeks (likely from improved microcirculation or reduced inflammation) and smoother texture after six to eight weeks of nightly use. Deep wrinkles don't vanish; you might see a 10-20% reduction in depth if the formulation is working, which is on par with a weak retinoid. If someone promises dramatic transformation in four weeks, they're selling hope. For better odds, combine your topical with the basics: broad-spectrum SPF 30+ every day (UV degrades collagen faster than any peptide can build it), adequate sleep (growth hormone pulses during deep sleep and drives repair), and hydration. A great cream on sun-damaged, sleep-deprived skin is like watering a plant in a dark closet. It won't die immediately, but it won't thrive.

Is there any real difference between a $30 copper peptide eye cream and a $150 one?

Sometimes yes, often no. The expensive jar usually has better packaging (airless pump that protects the peptide from oxidation), a more elegant sensory profile (less pilling, faster absorption), and a brand story that costs millions to build. Whether it has more active GHK-Cu is anyone's guess because concentration is rarely disclosed. A 2025 analytical study used inductively coupled plasma mass spectrometry to measure actual copper content in commercial GHK-Cu liposome formulations and found that some luxury brands delivered less copper per gram than mid-tier pharmacy brands ^[9]. The paper notes, 'Price does not correlate with encapsulation efficiency or peptide stability.' Translation: you might be paying for the box. What does matter: delivery technology. Liposomal encapsulation ^[8], solid lipid nanoparticles, or micelle-based carriers improve skin permeation and protect the peptide from degradation. Those cost more to produce, so a $30 cream in a jar with no advanced delivery is probably dumping naked peptide into an emulsion and hoping. A $60 cream in an airless pump with 'liposomal GHK-Cu' listed third might be a better bet, assuming the brand is honest. A $150 cream might add exotic botanicals that sound nice but do nothing, or it might use pharmaceutical-grade raw materials and third-party testing. You can't tell from the label. My advice: start mid-range ($40-70), look for airless or opaque packaging, check that GHK-Cu or copper peptide appears in the top five ingredients, and give it eight weeks. If you see improvement, great. If not, don't throw more money at a higher price tier. Move to a provider-reviewed source where you can get a compounded preparation at defined strength and track your response with photos.

What are the actual risks of using copper peptide around the eyes?

Topical GHK-Cu at cosmetic doses is generally well-tolerated, but copper is a transition metal that can cause irritation and, in excess, oxidative stress. The periorbital skin is thin and more permeable than cheek or forehead, so you're at higher risk for both absorption and reaction. A 2020 review on GHK-Cu safety notes that while the peptide itself shows antioxidant properties in some assays, free copper ions can participate in Fenton-like reactions that generate reactive oxygen species ^[3]. The complex is protective; the dissociated copper is not. If your cream has degraded or the formulation is unstable, you might be applying pro-oxidant copper to your eyelids every night. Signs of trouble: persistent redness, itching, or darkening of the skin (copper-induced hyperpigmentation is rare but documented in occupational exposure). A 2023 study on cigarette-smoke-induced muscle damage found that GHK-Cu rescued function via a sirtuin-1 pathway, suggesting systemic benefit ^[14], but that was intraperitoneal injection in mice, not topical human use. The point: copper has biologic activity. Don't assume it's inert just because it's in a pretty jar. Another concern: allergic contact dermatitis. Copper allergy exists (think cheap jewelry turning your skin green), though it's less common than nickel allergy. If you've reacted to copper IUDs or metal implants, patch-test any copper peptide product on your inner forearm for 48 hours before putting it near your eyes. Finally, if you're using other actives (retinol, AHAs, vitamin C), the combination can increase irritation or destabilize the peptide ^[4]. Alternate nights or use the copper peptide in the morning and retinol at night. And if you're pregnant, there's no safety data on topical GHK-Cu during pregnancy, so most dermatologists say skip it.

Can you make your own copper peptide eye cream or should you buy it ready-made?

You can buy raw GHK-Cu powder and try to formulate your own, but I wouldn't. Peptide chemistry is finicky: the copper-to-peptide ratio has to be right (typically 1:1 molar), the pH has to be controlled, and the mixture has to be sterile because you're putting it near a mucous membrane. Mess up any of those and you either get inactive peptide, free copper that irritates, or bacterial contamination that gives you an eye infection. A 2023 paper on GHK-Cu fluorescent sensing mentions that unbound GHK forms weak complexes with other divalent cations (zinc, manganese) if they're present in your formulation base, which competes with copper binding and reduces efficacy ^[15]. Home mixers rarely account for that. You also need a preservative (the FDA requires it for eye-area products), but many preservatives (parabens, benzyl alcohol) can degrade peptides over time ^[4]. If you want control over concentration without the formulation headache, ask a compounding pharmacy that follows USP <795> (non-sterile compounding) or <797> (sterile, if you're doing injection) to prepare a topical GHK-Cu cream or gel at a specified percentage. That's legal under 21 U.S.C. 353a if you have a patient-provider relationship and the pharmacy sources the bulk peptide from a supplier that meets quality standards ^[5]. The pharmacy handles pH adjustment, stability testing, and sterility. You get a product with a known concentration and a beyond-use date. Ready-made commercial eye creams are simpler and usually safe, but you sacrifice concentration transparency. Home-brew is risky unless you have a chemistry background and sterile compounding setup. Compounded professional preparations split the difference: you get the dose you want, made correctly, with some regulatory oversight. That's the route I'd pick if I were treating this seriously.

Do any legitimate before-and-after studies exist for copper peptide eye creams specifically?

No. Zero published trials have tested a commercial copper peptide eye cream against placebo with standardized photography and blinded assessment of periorbital wrinkles. The closest you get is full-face studies on photoaging or wound-healing studies that included the periorbital area incidentally. The 2008 review by Pickart describes GHK as a tissue-remodeling signal that improved skin thickness and reduced fine lines in small human studies, but those used researcher-prepared formulations at defined doses, not off-the-shelf products ^[16]. A 2025 paper on GHK-Cu hyaluronan conjugates showed increased collagen and angiogenic markers in bone and endothelial cell culture ^[17], which is interesting biology but not a wrinkle measurement. For before-and-after visuals, you're mostly stuck with brand-supplied images (which are uncontrolled and often retouched) or patient testimonials on forums, which suffer from survivorship bias: people who saw no result don't post. If you want something closer to real evidence, look for a dermatology practice that uses GHK-Cu topically and tracks outcomes with Canfield VISIA imaging or another validated wrinkle-analysis system. Some regenerative-medicine clinics do that for patients paying out-of-pocket. It's not a peer-reviewed trial, but it's better than guessing. The literature supports GHK-Cu's mechanism; the literature does not support any specific commercial eye cream as 'best.'

What's the deal with GHK-Cu in injectable fillers or combined therapies?

Some practitioners are loading GHK-Cu into hyaluronic acid fillers or using it as a 'bioregenerative' injectable alongside PRP (platelet-rich plasma) or microneedling. The idea is that GHK-Cu's collagen-stimulating and anti-inflammatory effects ^[2] will amplify the filler's volumizing result or speed healing after a procedure. It's plausible biology, but it's off-label and unstudied in controlled human trials. A 2025 study created an injectable hydroxyapatite microsphere filler loaded with GHK-Cu for anti-inflammatory and antioxidant effects ^[18]. The in-vitro data showed reduced cytokine release and oxidative markers, and a rat subcutaneous implant showed less inflammatory cell infiltrate at two weeks compared to plain hydroxyapatite. That's promising for soft-tissue augmentation, but the paper is silent on efficacy for wrinkles, and no human periorbital data exist. Another angle: a 2026 paper describes a Golgi-targeted copper delivery system using GHK-Cu to enhance copper-dependent enzyme activity during fascia regeneration ^[19]. The authors note that localized copper delivery improved collagen crosslinking and tissue remodeling in a mouse fascia-injury model. Again, that's wound healing and structural repair, not aesthetic smoothing of crow's feet. If your injector offers GHK-Cu 'skin booster' sessions, ask what concentration they're using, what the published safety data are, and how they're sourcing the peptide. If they can't answer, walk. If they're using a 503B outsourcing facility product or have a supervising physician and patient-specific prescriptions from a 503A pharmacy ^[5], that's at least following legal and safety norms. But understand: you're getting an experimental treatment with anecdotal support, not FDA-approved therapy. For most people, topical application or injection in other body sites where risk is lower makes more sense.

Frequently asked questions

Can I use copper peptide eye cream with retinol?

Yes, but not at the same time. Retinol and copper peptides can both irritate thin periorbital skin, especially during the retinization period. Use GHK-Cu in the morning and retinol at night, or alternate nights. A 2025 formulation review notes that combining copper with certain actives (ascorbic acid, alpha-hydroxy acids) can destabilize the peptide complex ^[4], so layering requires care.

Is GHK-Cu safe if I'm allergic to copper jewelry?

Probably not. If you've had contact dermatitis from copper bracelets or IUDs, you're at risk for reacting to topical copper peptide. Patch-test any product on your inner forearm for 48 hours before applying near your eyes. True copper allergy is less common than nickel allergy, but it exists.

How much copper is actually in a typical eye cream?

Most brands don't disclose it. A 2025 analytical study found commercial GHK-Cu formulations ranged from 10-200 ppm copper by mass ^[9], but those were full-face serums, not eye creams. If the ingredient list places copper peptide below the midpoint, you're likely under 1% total peptide, which translates to low-double-digit ppm copper.

Will copper peptide eye cream help dark circles?

Maybe, if your dark circles are vascular (bluish) rather than pigmentary (brown). GHK-Cu improved microcirculation and reduced inflammation in animal models ^[6], which could lighten vascular shadowing. Pigmentary circles need a different approach (niacinamide, tranexamic acid). For hollowing, no topical fixes volume loss; you need filler or fat transfer.

Can I store my copper peptide eye cream in the fridge?

Yes, and it might help. Cool temperatures slow peptide degradation and oxidation. Refrigeration won't fix a poorly formulated product, but if you've got a high-quality cream in an airless pump, keeping it chilled can extend shelf life a few months past the printed date. Just don't freeze it; ice crystals disrupt emulsions.

Is GHK-Cu better than Matrixyl for eye creams?

No direct comparison exists. Matrixyl (palmitoyl pentapeptide-4) stimulates collagen via a different signaling pathway and has a few small human studies showing wrinkle reduction. GHK-Cu has broader gene-expression effects ^[2] but less cosmetic-specific data. Ideally, you'd want both in a formula, but most brands pick one to feature. Neither is a magic bullet.

Can I use copper peptide eye cream while pregnant?

There's no safety data on topical GHK-Cu during pregnancy. Copper is an essential trace element, but the peptide's signaling effects haven't been studied in pregnancy. Most dermatologists recommend avoiding non-essential actives in the first trimester. If you want to use it later, discuss it with your OB and keep it away from mucous membranes.

Does copper peptide eye cream work for puffiness?

It might reduce inflammatory puffiness (from poor sleep, allergies, or histamine response) because GHK-Cu has documented anti-inflammatory effects ^[2]. It won't fix structural fat-pad prolapse or fluid retention from salt or alcohol. Caffeine-containing eye creams are more reliably effective for temporary puffiness because caffeine is a vasoconstrictor.

How do I know if the GHK-Cu in my eye cream is actually stable?

You usually don't, unless the brand publishes stability data (rare). Look for airless or opaque packaging, a short ingredient list, and liposomal or encapsulated delivery. A 2025 paper found that free GHK-Cu degrades in the presence of air, light, and phenoxyethanol preservative ^[4]. If your cream is in a jar and turns blue-green after a few weeks, it's oxidizing.

Can I get prescription-strength copper peptide for my eyes?

Yes, from a compounding pharmacy under 21 U.S.C. 353a with a patient-specific prescription ^[5]. The pharmacy can prepare a defined-concentration topical GHK-Cu cream or serum, usually 0.5-3% w/v, with controlled pH and sterility. This gives you the closest thing to 'evidence-matched' dosing outside a research setting. Your dermatologist or regenerative-medicine provider can write the prescription.

Is there a risk of copper overload from daily eye cream use?

Systemic copper overload from topical eye cream is extremely unlikely. Skin absorption is limited, and the periorbital area is small. Local irritation or hyperpigmentation is a bigger concern if the formula is unstable or too concentrated. People with Wilson disease (genetic copper-accumulation disorder) should avoid copper-containing topicals altogether, but that's a rare condition.

Can I apply copper peptide eye cream after microneedling?

Not immediately. Microneedling creates microchannels and temporary barrier disruption. Applying a multi-ingredient cosmetic (especially one with a transition metal) on broken skin increases irritation risk and could drive contaminants deeper. Wait 24-48 hours, then reintroduce your peptide cream. A 2025 study combined GHK-Cu with microneedling for wound healing in mice and saw benefit ^[20], but that was sterile peptide solution, not a jar cream.

What's the difference between GHK-Cu in a serum versus a cream for the eyes?

Serums are typically water-based or silicone-based with smaller molecules and faster absorption. Creams are emulsions (oil-in-water or water-in-oil) with occlusives that slow evaporation. For peptides, a serum or light gel delivers the active faster and feels less heavy, which most people prefer around the eyes. A cream provides more barrier protection, which can help if your skin is dry or sensitized.

Will a copper peptide eye cream help crepey eyelid skin?

Maybe a little, but don't expect dramatic tightening. Crepey lids are from collagen loss, elastin degradation, and fat atrophy. GHK-Cu can stimulate some collagen synthesis ^[2], but topical delivery to the deep dermis is limited. You'd likely see better results from in-office radiofrequency, microneedling with growth factors, or a blepharoplasty consult if it's severe. A good eye cream is supportive, not curative.

Sources

1. 21 CFR 201.128, FDA intended uses definition: Cosmetics are not required to prove efficacy, only safety from immediate harm, as they are not classified as drugs unless they make therapeutic claims.
2. Regenerative and Protective Actions of the GHK-Cu Peptide (PMID 29986520): 2018 gene-expression study found GHK-Cu influenced genes related to collagen synthesis, antioxidant response, and angiogenesis.
3. The potential of GHK as an anti-aging peptide (PMID 35083444): GHK-Cu improved wound contraction, epidermal thickness, and collagen deposition in animal models at concentrations typically 0.5-2 mM.
4. Topically applied GHK as an anti-wrinkle peptide (PMID 39963574): Commercial formulations rarely specify the molar ratio of copper to peptide, pH, or peptide stability; GHK-Cu is most stable at pH 5-7 and degrades with common preservatives.
5. 21 U.S.C. 353a, pharmacy compounding statute: Compounded preparations are legal under 21 U.S.C. 353a if there is a patient-provider relationship and the pharmacy follows quality standards.
6. GHK-Cu-liposomes accelerate scald wound healing in mice (PMID 28370978): Mouse scald-wound study using GHK-Cu liposomes at 2 mg/mL showed accelerated re-epithelialization within seven days and improved collagen deposition by day fourteen.
7. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation (PMID 37062921): Human ex-vivo skin testing found that GHK-Cu combined with hyaluronic acid increased collagen IV expression more than either compound alone.
8. Liposomes as Carriers of GHK-Cu Tripeptide for Cosmetic Application (PMID 37896245): Liposomal GHK-Cu encapsulation efficiencies range from 50-85%, and unencapsulated peptide degrades rapidly in the presence of air, light, and common preservatives.
9. Novel Applications of CE-ICP-MS/MS: Monitoring GHK-Cu Encapsulation (PMID 39451062): Analytical study using capillary electrophoresis and mass spectrometry found actual peptide content varied from 60-110% of label claim even in pharmaceutical-grade batches.
10. Injectable Peptide Therapy: A Primer for Orthopaedic Physicians (PMID 41476424): GHK-Cu is sometimes used in tendon and fascia repair at 2-10 mg per injection site, though off-label and largely uncharted.
11. Safety and Efficacy of Approved and Unapproved Peptide Therapies (PMID 41966639): GHK-Cu is listed among unapproved peptides being tried for musculoskeletal injuries, with the review stressing the lack of large human trials.
12. GHK-Cu (II) improved healing outcome in a rat model of ACL reconstruction (PMID 25731775): Rat ACL-reconstruction study found GHK-Cu improved early collagen alignment and tensile strength at week four, but the effect faded by week twelve.
13. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions (PMID 42123471): Review mentions GHK-Cu for facial rejuvenation but flags the absence of dosing consensus and notes that many providers use it in combination with other peptides.
14. GHK-Cu rescues cigarette smoking-induced skeletal muscle dysfunction (PMID 36905132): Study found that GHK-Cu rescued cigarette-smoke-induced muscle dysfunction via a sirtuin-1 pathway in mice, suggesting systemic benefit.
15. Phenothiazine-Based Cu(II)-Selective Fluorescent Sensor (PMID 37830186): Paper mentions that unbound GHK forms weak complexes with other divalent cations (zinc, manganese) if present, which competes with copper binding.
16. The human tri-peptide GHK and tissue remodeling (PMID 18644225): 2008 review describes GHK as a tissue-remodeling signal that improved skin thickness and reduced fine lines in small human studies using researcher-prepared formulations at defined doses.
17. Copper Complexes with New GHK-Hyaluronan Conjugates (PMID 40123442): Study showed increased collagen and angiogenic markers in bone and endothelial cell culture using GHK-Cu hyaluronan conjugates.
18. An injectable hydroxyapatite microsphere filler loaded with GHK-Cu (PMID 40716276): In-vitro data showed reduced cytokine release and oxidative markers, and a rat subcutaneous implant showed less inflammatory cell infiltrate at two weeks.
19. Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins (PMID 41371501): Study describes a Golgi-targeted copper delivery system using GHK-Cu to enhance copper-dependent enzyme activity during fascia regeneration in a mouse model.
20. Food-Derived Tripeptide-Copper Self-Healing Hydrogel for Infected Wound Healing (PMID 39902373): Study combined GHK-Cu with microneedling for wound healing in mice and saw benefit, though using sterile peptide solution, not a jar cream.